Diabetes & Obesity
Type 2 Diabetes Mellitus (T2DM):
Pathophysiology and Therapeutic Strategy
Overview
Type 2 Diabetes Mellitus (T2DM) is a chronic metabolic disorder characterized by elevated blood glucose levels (hyperglycemia) resulting from insulin resistance and relative insulin deficiency.
Etiology
The development of T2DM is influenced by a combination of genetic predisposition and lifestyle factors, including:
-
Poor dietary habits
-
Low physical activity
-
Obesity, particularly visceral obesity, which represents the primary risk factor for disease onset
Clinical Manifestations
Typical symptoms of Type 2 Diabetes Mellitus include:
-
Excessive thirst and frequent urination
-
Persistent fatigue
-
Blurred vision
-
Delayed wound healing
Complications
If not adequately controlled, T2DM may lead to severe systemic complications, including:
-
Cardiovascular diseases (atherosclerosis, myocardial infarction, stroke)
-
Nephropathy (progressive kidney damage)
-
Neuropathy (peripheral nerve damage)
-
Retinopathy (vision impairment and potential blindness)
Obesity and Its Role
Obesity is defined as excessive accumulation of adipose tissue that disrupts metabolic balance and adversely affects overall health.
It plays a central role in the development of insulin resistance and the metabolic dysregulation associated with Type 2 Diabetes Mellitus.
Project Strategy: Therapeutic Normalization of Metabolic Processes and Glycemic Control
The project aims to develop a therapeutic solution that ensures effective regulation of glucose metabolism, restoration of insulin sensitivity, and sustainable weight management through a multi-target approach encompassing the following mechanisms:
-
Stimulation of insulin secretion
Enhances glucose-dependent insulin release, reducing hyperglycemia while minimizing the risk of hypoglycemia. -
Slowing of gastric emptying
Delays gastric emptying to moderate postprandial glucose spikes, promoting gradual absorption and stable glycemic control. -
Appetite reduction
Modulates central appetite-regulating pathways, reducing hunger and contributing to clinically meaningful weight loss. -
Improved insulin sensitivity
Increases peripheral tissue responsiveness to insulin, enabling efficient cellular glucose uptake and utilization.
Application is no longer available.
Application is no longer available.
For more information,
see our presentation: download here
Licensing Service:
We offer cost-effective licensing of our proprietary vector technology to external partners. For more information on how to license our vector, please contact us here.
